Revacure Lifesciences LLP

  • REVACURE LIFESCIENCES FACILITY IMAGES
About Revacure Lifesciences LLP

Revacure is value based organization established to manufacture high quality oncology injectable formulations in strict compliance to International and local regulatory norms. The plant is approved by various regulating authorities like European (EUGMP), FDA Philippines, Colombia (INVIMA), DIGEMID Peru, IFDA (Iran), World Health Organization (WHO GMP) etc. Revacure manufactures various Oncology Injectable Formulations for all major Pharma Companies like Sun Pharma, Cipla, Emcure, Mylan, Intas, Zydus, Mankind, Cadila Healthcare, Glenmark and many more....

Certifications
  • CE
    CE
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
  • Other
  • IN
  • 2017
    On CPHI since
  • 5
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Distributor/Import Export
Manufacturer/Innovator
Packaging supplier/manufacturer
Pharmaceutical company
Wholesale/Retail
Primary activities
Contract Manufacturer
Contract Research Organisation
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Supply Chain
Contact info
  • Plot no 58 to 67, Sector B 1, AKVN Industrial Area,Umaria Dungaria,, Jabalpur, India
Meet us at

CPHI & PMEC India 2024

India Expo Centre, Greater Noida, Delhi NCR
26 Nov 2024 - 28 Nov 2024

Products from Revacure Lifesciences LLP (5)

  • Paclitaxel Injection IP/USP 30/100/260 mg

    Product Paclitaxel Injection IP/USP 30/100/260 mg

    Each ml contains :Paclitaxel IP/USP 6 mgCremophor EL 35 USP q.s.Dehydrated Alcohol IP/USP q.s.
  • Cytarabine Injection BP 100/500 mg

    Product Cytarabine Injection BP 100/500 mg

    Each ml Contains:Cytarabine IP/BP 100 mgSterile Water for Injection IP/BP q.s.
  • Dacarabazine Injection USP 200/500 mg

    Product Dacarabazine Injection USP 200/500 mg

    Each Vial Contains:Dacarabazine USP 200/500 mgExcipients q.s.
  • Docetaxel Injection IP/USP 20/80 mg

    Product Docetaxel Injection IP/USP 20/80 mg

    Each Combipack Contains:1 vial of Docetaxel concentrate IP/USPEach single dose vial contains:Docetaxel Trihydrate IP equivalent to anhydrousDocetaxel 20/80 mgPolysorbate 80 IP/USP q.s.1 vial of solvent for Docetaxel concentrate IP/USP Alcohol (95%) 13% w/vSterile water for Injection IP/USP q.s. to 1.5 ml
  • Gemcitabine Injection IP/USP 200/1000 mg

    Product Gemcitabine Injection IP/USP 200/1000 mg

    Each Vial Contains:Gemcitabine Hydrochloride IP/USP e.q. to Gemcitabine 200/1000 mgMannitol IP/USP q.s.Sodium acetate IP/USP q.s.

Revacure Lifesciences LLP Resources (1)

  • Video REVACURE LIFESCIENCES FACILITY VIDEO

    Revacure is a value based organization established to manufacture high quality formulations in strict compliance to international and local regulatory norms. The company is promoted by highly qualified and accomplished doctors and pharma professionals.
    Revacure has a state of the art Oncology  Injectable Formulations (Anti-cancer)manufacturing plant on a 12500 Sq. m plot at AKVN Industrial Area, Jabalpur. The company is having a complete technical support from world renowned pharma consultancy cGMP Pharma 'n' Plans Pvt Ltd for Design, Engineering, Qualification, Validation, on-going GMP Compliance, Quality Assurance, Training and Internal Audits.The plant is WHO-GMP certified and the EU-GMP audit is scheduled in Jan 2018.